November 2021

Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months A Swedish Total-Population Cohort Study

Swedish Study on COVID 19 Vaccine Effectiveness Against Risk of Symptomatic Infection, Hospitalization, and Death

Nationwide Swedish study shows COVID 19 vaccine effectiveness wanes over time, in risk of symptomatic and severe COVID-19 infection.

November 27, 2021
Australian aboriginal communities military police vaccination campaign

Australian Aboriginal COVID Vaccine Campaign

Australia NT chief Gunner utilizes military and police as part of a COVID vaccine task group, aimed to isolate and vaccinate aboriginals.

November 26, 2021
Abstract 10712 Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test a Warning

mRNA COVID Vaccines increase ACS Risk measured by PULS Cardiac Test

New findings show mRNA COVID vaccines increase ACS risk (heart attack risk) from 11% 5year ACS risk to 25% 5 year ACS risk. Full analysis.

November 25, 2021
Profusa biosensor picture

Profusa Biosensor

Profusa has developed an injectable biosensor capable of monitoring body chemistry in real time, transmitted wirelessly over WiFi to a device which connects to servers allowing remote monitoring of military personnel’s body chemistry.

November 25, 2021

End of content

No more pages to load